J. Loffredo

发表

Gag-Specific CD 8 T Lymphocytes Recognize Infected Cells before AIDS-Virus Integration and Viral Protein Expression 1

D. Watkins, O. Yang, J. Lifson, 2007 .

Gag-Specific CD8+ T Lymphocytes Recognize Infected Cells before AIDS-Virus Integration and Viral Protein Expression1

D. Watkins, O. Yang, J. Lifson, 2007, The Journal of Immunology.

Patterns of CD8 (cid:1) Immunodominance May Inﬂuence the Ability of Mamu - B * 08 -Positive Macaques To Naturally Control Simian Immunodeﬁciency Virus SIVmac239 Replication (cid:1) †

D. Watkins, T. Friedrich, S. Musani, 2008 .

Molecular typing of major histocompatibility complex class I alleles in the Indian rhesus macaque which restrict SIV CD8+ T cell epitopes

D. Watkins, W. Rehrauer, Gretta Borchardt, 2007, Immunogenetics.

Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity

J. Sidney, H. Bui, A. Sette, 2005, Immunogenetics.

The Major Histocompatibility Complex Class II Alleles Mamu - DRB1 * 1003 and -DRB1 * 0306 Are Enriched in a Cohort of Simian Immunodeﬁciency Virus-Infected Rhesus Macaque Elite Controllers (cid:1)

M. Carrington, Y. Qi, D. Watkins, 2007 .

Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial.

P. Ascierto, J. Larkin, A. Arance, 2020, The Lancet. Oncology.

Infection with “Escaped” Virus Variants Impairs Control of Simian Immunodeficiency Virus SIVmac239 Replication in Mamu-B*08-Positive Macaques

D. Watkins, S. Lank, D. O’Connor, 2009, Journal of Virology.

CD8+ T Cells from SIV Elite Controller Macaques Recognize Mamu-B*08-Bound Epitopes and Select for Widespread Viral Variation

A. Hughes, J. Sidney, A. Sette, 2007, PloS one.

The Major Histocompatibility Complex Class II Alleles Mamu-DRB1*1003 and -DRB1*0306 Are Enriched in a Cohort of Simian Immunodeficiency Virus-Infected Rhesus Macaque Elite Controllers

M. Carrington, Y. Qi, D. Watkins, 2007, Journal of Virology.

High Viremia Is Associated with High Levels of In Vivo Major Histocompatibility Complex Class I Downregulation in Rhesus Macaques Infected with Simian Immunodeficiency Virus SIVmac239

T. Friedrich, Y. Klimentidis, E. Rakasz, 2010, Journal of Virology.

The Antiviral Efficacy of Simian Immunodeficiency Virus-Specific CD8+ T Cells Is Unrelated to Epitope Specificity and Is Abrogated by Viral Escape

D. Watkins, T. Friedrich, Jason J. Stephany, 2006, Journal of Virology.

Tat28-35SL8-Specific CD8+ T Lymphocytes Are More Effective than Gag181-189CM9-Specific CD8+ T Lymphocytes at Suppressing Simian Immunodeficiency Virus Replication in a Functional In Vitro Assay

D. Watkins, E. Rakasz, J. P. Giraldo, 2005, Journal of Virology.

Mamu-B*08-Positive Macaques Control Simian Immunodeficiency Virus Replication

M. Carrington, Y. Qi, D. Watkins, 2007, Journal of Virology.

Repeated intravaginal inoculation with cell-associated simian immunodeficiency virus results in persistent infection of nonhuman primates.

T. Friedrich, E. Rakasz, A. Weiler, 2006, The Journal of infectious diseases.

Two MHC Class I Molecules Associated with Elite Control of Immunodeficiency Virus Replication, Mamu-B*08 and HLA-B*2705, Bind Peptides with Sequence Similarity12

John Sidney, Alessandro Sette, Nancy A. Wilson, 2009, The Journal of Immunology.

Comprehensive Immunological Evaluation Reveals Surprisingly Few Differences between Elite Controller and Progressor Mamu-B*17-Positive Simian Immunodeficiency Virus-Infected Rhesus Macaques

A. Hughes, J. Sidney, A. Sette, 2008, Journal of Virology.

Major Histocompatibility Complex Class I Alleles Associated with Slow Simian Immunodeficiency Virus Disease Progression Bind Epitopes Recognized by Dominant Acute-Phase Cytotoxic-T-Lymphocyte Responses

Todd M. Allen, Kendall C. Krebs, A. Hughes, 2003, Journal of Virology.

Lymphocyte Responses to SIV T + Not Appear to Be Involved in CD8 MHC Class I Molecule, Mamu-B*01, Does The High Frequency Indian Rhesus Macaque

J. Sidney, D. O’Connor, Wilfried Bardet, 2017 .

Simian Immunodeficiency Virus-Specific CD8+ T Cells Recognize Vpr- and Rev-Derived Epitopes Early after Infection

D. Watkins, N. Wilson, J. Sacha, 2010, Journal of Virology.

Effective Simian Immunodeficiency Virus-Specific CD8+ T Cells Lack an Easily Detectable, Shared Characteristic

D. Watkins, R. Johnson, E. Rakasz, 2009, Journal of Virology.

Patterns of CD8+ Immunodominance May Influence the Ability of Mamu-B*08-Positive Macaques To Naturally Control Simian Immunodeficiency Virus SIVmac239 Replication

D. Watkins, T. Friedrich, S. Musani, 2007, Journal of Virology.

Not All Cytokine-Producing CD8+ T Cells Suppress Simian Immunodeficiency Virus Replication

D. Watkins, T. Friedrich, E. Rakasz, 2006, Journal of Virology.

The High Frequency Indian Rhesus Macaque MHC Class I Molecule, Mamu-B*01, Does Not Appear to Be Involved in CD8+ T Lymphocyte Responses to SIVmac2391

Bjoern Peters, J. Sidney, A. Sette, 2005, The Journal of Immunology.

A computational resource for the prediction of peptide binding to Indian rhesus macaque MHC class I molecules.

A Sette, J Sidney, Bjoern Peters, 2005, Vaccine.

Identification of Seventeen New Simian Immunodeficiency Virus-Derived CD8+ T Cell Epitopes Restricted by the High Frequency Molecule, Mamu-A*02, and Potential Escape from CTL Recognition1

J. Sidney, A. Sette, B. Mothé, 2004, The Journal of Immunology.

Potential Escape from CTL Recognition Frequency Molecule , Mamu-A * 02 , and Cell Epitopes Restricted by the High T + Immunodeficiency Virus-Derived CD 8 Identification of Seventeen New Simian

J. Sidney, A. Sette, B. Mothé, 2004 .

Cytotoxic T-Lymphocyte Escape Does Not Always Explain the Transient Control of Simian Immunodeficiency Virus SIVmac239 Viremia in Adenovirus-Boosted and DNA-Primed Mamu-A*01-Positive Rhesus Macaques

Kendall C. Krebs, D. Watkins, D. O’Connor, 2005, Journal of Virology.

Mauritian Cynomolgus Macaques Share Two Exceptionally Common Major Histocompatibility Complex Class I Alleles That Restrict Simian Immunodeficiency Virus-Specific CD8+ T Cells

Jennifer J. Lhost, D. O’Connor, Wilfried Bardet, 2009, Journal of Virology.

Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge

D. Watkins, J. Lifson, G. Shaw, 2009, Journal of Virology.

Beyond Mamu-A*01+ Indian Rhesus Macaques: Continued Discovery of New MHC Class I Molecules that Bind Epitopes from the Simian AIDS Viruses

D. Watkins, J. Loffredo, Laura E. Valentine, 2007 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Simian immunodeficiency virus-specific CD4+ T cells from successful vaccinees target the SIV Gag capsid

D. Watkins, N. Wilson, R. Rudersdorf, 2010, Immunogenetics.

Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer.

N. Agarwal, E. Attiyeh, A. Hansen, 2023, Clinical genitourinary cancer.

Characterization of Mauritian Cynomolgus Macaque FcγR Alleles Using Long-Read Sequencing

Trent M. Prall, Hailey E. Bussan, A. Yamniuk, 2018, The Journal of Immunology.

High Reproducibility of ELISPOT Counts from Nine Different Laboratories

K. Silina, D. Roen, P. Lehmann, 2015, Cells.

Mauritian Cynomolgus Macaques Share Two Exceptionally Common Major Histocompatibility Complex Class I Alleles That Restrict Simian Immunodeficiency Virus-Specific CD8+ T Cells

Jennifer J. Lhost, D. O’Connor, Wilfried Bardet, 2009, Journal of Virology.

Abstract SY09-01: Next-generation anti-CTLA-4 antibodies

A. Korman, R. Vuyyuru, M. Selby, 2017 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, David M. Schauder, 2016, Journal for ImmunoTherapy of Cancer.

Abstract 4551: Preclinical characterization of novel anti-CTLA-4 prodrug antibodies with an enhanced therapeutic index

Natalie A. Bezman, B. Irving, John J. Engelhardt, 2020, Immunology.

Abstract 4552: Preclinical characterization of BMS-986218, a novel nonfucosylated anti–CTLA-4 antibody designed to enhance antitumor activity

Natalie A. Bezman, John J. Engelhardt, J. Loffredo, 2020, Immunology.